Select Committee on European Union Minutes of Evidence


Examination of Witnesses (Questions 500 - 505)

THURSDAY 3 APRIL 2008

Ann Keen, Ms Triona Norman, Mr Peter Jones and Mrs Elisabeth Buggins

  Q500  Baroness Neuberger: Minister, I have to declare an interest which has always struck me as a rather odd one: my brother-in-law is involved in transplantation, particularly kidneys and livers, and I would really prefer you to know that. My Lord Chairman has already said that we have heard very different evidence from people about this question of presumed consent, and at the moment public expectation seems to have been raised, particularly by some very prominent individuals and organisations, that moving to a system of presumed consent would increase organ donation rates. You have already said that we have to have that debate—you have already touched on some of this—but the specific questions to which we want to get answers from you are about the extent to which you think that presumed consent might raise alarm amongst some groups, because they really might be fearful that their organs are going to be taken and that might reduce willing consent, willing donation. Also, were we to go to this, how could a legal basis be introduced and would this require a new Act? I realise that those two specific issues are in a much broader debate that you have already highlighted.

  Ann Keen: It is so very complex. All the people I have heard who support presumed consent—of which I am one—is because there is a keen desire for transplantation to take place. That is the only platform from which people are seen to come. How those rates and how that is influenced is what the Taskforce is looking at. I am not privy to how that Taskforce is developing at the moment because they are yet to report back to us. Of course everybody knows Elisabeth is chairing that. I do not want to say that I do not want to say any more but it is very difficult to say any more because of that situation. The media, as always, is either very helpful or not. In the debate that is taking place—which you have had, of course, here already with hybrid embryo research—everybody then becomes very emotional and misguided in many instances as to what is taking place. People will remember serious incidents, like Alder Hey. If they do not remember, somebody will come up and remind them as to what has happened there and panic people. That is why the work the Taskforce is doing is so, so important, and responsible people telling the truth as to what will happen. There have been people who, to be honest, have not been honest as to what will happen. The more that we can get patients as advocates of how important this is the better, recognising and very much valuing the fact that the families' wishes at the end will still be taken fully into account.—and that nobody could sign up to the fact that that would not happen. As I still feel a health professional myself, there is no way that that could ever happen. Therefore, we do need to bring in all of the experts but also all the lay people as well to talk about how they feel in the best way we can do this, and your report will help considerably and people like yourselves will help us considerably to do this important work.

  Mrs Buggins: Shall I describe the approach we are taking?

  Q501  Baroness Neuberger: I think that would be useful. Obviously you will look at al the evidence we have, but the European experts we have talked to have not really thought it would make a huge amount of difference. They say do it or not, but they have not thought that that is really what made the difference. You have touched on that with the Spanish circumstances.

  Mrs Buggins: Certainly Spain had presumed consent for ten years—back in 1979 to 1989, I believe—and it made no difference to their organ donation rate. That is interesting, but that then set the context for all the other changes they brought about in 1989, so we are looking at those two things in tandem really and wondering what difference it would make in the UK context. The approach we have taken, because it is so complex, is to set up six expert working groups looking at the practical, clinical, legal, ethical, cultural and communication aspects of different consent regimes, to try to understand what the evidence currently would tell us about whether presumed consent would be a better option for the UK or not. I would like to say that we have been put under no pressure to come up with a particular answer, so this is an honest inquiry, and we are committed to producing the report, based on the evidence that is currently available to us, in the summer this year and also in that report to highlight further questions to which we feel we need answers if we cannot come to a definitive view at that point. Again we are indebted to a huge number—I have a list here—of experts who are on those six working groups and some fascinating debate is underway. They are due to report back to the Taskforce by the end of May, so that we may then formulate our report in the summer. I am not really in a position to say what the conclusion is going to be at the moment but we are addressing it very seriously and thoroughly and it is a fascinating debate.

  Q502  Baroness Neuberger: I presume there would be some kind of changed needed for the Human Tissue Act if you go down that path but at the moment you are not going to discuss that. Is that right?

  Mr Jones: I am Peter Jones, Branch Head of the Human Tissue Branch at the Department of Health. We look after the Human Tissue Act legislation. I am also providing secretariat help to Elisabeth and the Taskforce work on presumed consent. The extent to which the law would need to be changed depends on how far we go—which is an obvious statement. The way the law works at the moment is that where there was a decision made by the deceased person one way or the other when they were alive, that endures beyond death and has legal force. If that is not the case, the Human Tissue Act requires you to get consent from either someone nominated by the person when they were alive to make those sorts of decisions for them or to go to someone in what is called a qualifying relationship, which is usually family member—it is ranked from spouse down to a friend of longstanding. Anything that involved, in the absence of any decision one way or the other by the deceased, making a presumption or an assumption, in those circumstances would need a change in the primary legislation. To what extent we would need change would depend on the Taskforce's findings.

  Baroness Neuberger: Thank you very much indeed. Could I just say that it is great about Chris Rudge.

  Q503  Lord Kirkwood of Kirkhope: Minister, thank you for your appearance and your evidence. As someone who has come new to this whole subject, you only need to have been listening to our hearings for ten minutes to understand that we are really dealing with public ignorance. My own view has been completely transformed just by listening to what is being done. Also I think we would acknowledge that the Government have done a lot and that is well recognised. Public awareness is part of the problem. I would like to put it to you that it is, and get an assurance that the Government does understand the importance of trying not to manipulate but to achieve informed consent in the best way that we can. I would like an assurance about that. I would like to know what other initiatives or projects the Government may have in mind, bearing in mind I have a very clear recollection of the mid 1990s, when AIDS became a problem, that the TV promotional campaigns were very effective and, indeed, some of the smoking campaigns more recently have been very effective. If Parliament does believe in making progress in this area—and I believe the evidence is that they do—can you really do that without putting some effort and money inevitably into some of these publicity campaigns that could get the informed public into a situation where they can make decisions for themselves? Do you have a budget within the EU Comprehensive Spending Review to help you do that? The Taskforce, fully funded as it is, as Elisabeth Buggins was right to point out—and that is welcome—does not have an element for public awareness raising in terms of publicity that I am aware of.

  Ann Keen: This is a very important question. Yes, we are funding the Taskforce for more public awareness. That will take place.

  Q504  Lord Kirkwood of Kirkhope: Is that known?

  Ann Keen: Yes.

  Mrs Buggins: £4.5 million over the next two years.

  Ann Keen: National Health Service Blood and Transplant and bodies like that—and I think our welcome appointment today will make a huge difference—and newspaper campaigns have been supportive. Last Saturday's Sun was very helpful. I think the soaps are a good way in. Sport in particular. We work very closely now with the Football Foundation in the Department of Health. Rugby want to come in. All of the sports people can help us. When we were talking this morning, Elisabeth came up with the idea that we should make a film. It would be a very powerful film. I do not want to steal her idea, but I think it would be. Having seen the Diving Bell and the Butterfly in the last few weeks and seen how powerful that media is, this would cross all languages and cultures, and there is so much now that we are ready to do and so many people ready to do it. I met Graham Bruchete outside and he is going to give me more examples of his work when the Committee is ended. He has received a heart and lung transplant and is going around schools, and getting into schools is so important. The Health Service, as we have said in previous answers, needs education. Professions do. There is such a powerful media out there: Casualty, Holby City, all of those, are powerful programmes for getting messages across. But funding needs to be there too.

  Q505  Lord Kirkwood of Kirkhope: That is a helpful reassurance. The other point that struck me, which I was completely ignorant about, is that even when people are on the Organ Donor Register family members can resist. That is a trickier problem, I guess, from a public awareness point of view. Just to get people to sign up is perhaps simpler than trying to get across to families that people have made a choice and it is something that really ought to be respected. That is an important part of the public awareness campaign as well I hope.

  Mrs Buggins: What you have just said is so important. One of the things that was really interesting, looking at the data around the donation in this country, is that being on the Organ Donor Register does not necessarily mean that you donate, as you say, because family members are so important. But, also, the way the NHS operates at the time of that person's death has a big impact which is something that the Taskforce Report sought to address. It is also interesting that people who are on the register do not donate necessarily in proportion to the population. Perhaps I can explain that a bit more clearly. People who are on the Organ Donor Register tend to be people who are in the higher socio-economic groups; I understand that the people who donate tend to be in the lower socio-economic groups. Again we need research. We do not understand why. There does seem to be some suggestion that the degree of confidence that people have in their professional carers at the time of death leads to their willingness or not to donate. We do need to understand a great deal more about why people donate and why they do not donate but a publicity campaign is overdue.

  Chairman: It illustrates the need for research again. We are immensely grateful to you for coming to talk to us—some of you, yet again. Minister we are very grateful that you have given us the time. I suppose we have discovered just how immensely complex a problem this is but I think the one message we have taken is that, whatever else you do, if you do not have the system in place to take the organ, and transplant it at the time when someone is prepared to give it, then whatever else you spend your money on will be lost. I suppose that is the core message that has come across to us and of course it was a central message in the Taskforce report. I suppose we would be saying to you that we have to look at the EU proposals but as far as the UK is concerned, the top priority will be to put your system in place. This is what we have been told both by the people we have heard from across Europe and from UK witnesses. We recognise how distressing it is that so many people sit on waiting lists for organ transplants and that relatives lose their family members. We are very aware of how important all this is. We will do our best with all the evidence we have received and we wish you well in trying to make it all work for the UK. Thank you very much indeed.


 
previous page contents

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2008